Financhill
Back

Agios Pharmaceuticals 10K Form

Sell
45

AGIO
Agios Pharmaceuticals

Last Price:
48.33
Seasonality Move:
-0.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive AGIO News And Ratings

See the #1 stock for the next 7 days that we like better than AGIO

AGIO Financial Statistics

Sales & Book Value

Annual Sales: $26.82M
Cash Flow: $-100.01M
Price / Cash Flow: 0
Annual Sales: $13.11
Price / Book: 3.79

Profitability

EPS (TTM): -6.32000
Net Income (TTM): $-352.62M
Gross Margin: $23.94M
Return on Equity: -39.69%
Return on Assets: -35.05%

Agios Pharmaceuticals Earnings Forecast

Key Agios Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 11 years for AGIO is 89.26%.
  • The Selling, General & Administrative Expenses for AGIO have been equal to 447.02% of Gross Profit Margin.
  • The Research & Development expenses have been 1,101.76% of Revenue.
  • The Interest Expense is -5.45% of Operating Income.
  • The Net Earning history of AGIO is -1,312.63% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 4 years.

Agios Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AGIO
CUSIP: 00847X
Website: agios.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 12.84
Quick Ratio: 11.64

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AGIO Technical Analysis vs Fundamental Analysis

Sell
45
Agios Pharmaceuticals (AGIO) is a Sell

Is Agios Pharmaceuticals a Buy or a Sell?